VSTM2A and colorectal carcinoma: According to studies, VSTM2A downregulation and VSTM2A DNA promoter hypermethylation are linked to poor prognosis of CRC patients and colorectal tumorigenesis is affected by the hyperactivation of the Wnt/β-catenin signalling pathway.